A vaccine patch.
A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice.
The research, conducted in partnership with Brisbane biotechnology company Vaxxas, tested the Hexapro SARS-CoV-2 spike vaccine using the Vaxxas high-density microarray patch (HD-MAP) technology, and the results found the patch was far more effective at neutralising COVID-19 variants.
UQ’s Dr Christopher McMillan said the vaccine patch appeared to counteract new variants more effectively than the current SARs-CoV-2 vaccine delivered by injection.
“The high-density microarray patch is a vaccine delivery platform that precisely delivers the vaccine into the layers of the skin which are rich in immune cells,” Dr McMillan said.
“We found that vaccination via a patch was approximately 11 times more effective at combatting the Omicron variant when compared with the same vaccine administered via a needle.”
He said the results extended further than just the Hexapro vaccine.
“So far, every vaccine type we have tested through the patch, including subunit, DNA, inactivated virus and conjugate produces superior immune responses compared to traditional needle vaccination methods,” he said.
UQ’s Dr David Muller said currently-available vaccines may not be as effective because of the constantly emerging new variants of COVID-19, and this has left researchers at a crossroads.
“This decreased effectiveness was highlighted by the Omicron variant, which contains over 30 mutations in the spike protein,” Dr Muller said.
“The large number of mutations have given the virus the ability to evade the immune responses generated by the current vaccines.
“However, the patch technology has the potential to offer a new – and more effective – weapon in our arsenal, at a time where new variants are mutating at a rapid rate.
“The patches are not only more effective against emerging variants but are also far easier to administer than needle-based vaccines.
“But, it is important to stress that existing vaccines are still an effective way of combatting serious illness and disease from this virus and it is not the time to drop our guard.”
Vaxxas CEO, David Hoey said this is further evidence of the game-changing potential the technology platform could have in helping nations better respond to global health emergencies, like the current and future pandemics.
“We are continuing to scale-up our manufacturing capabilities and accelerate product development in preparation for large-scale clinical trials,” he said.
“This includes construction of our first manufacturing facility in Brisbane to support the transition to commercialising of our HD-MAP vaccine candidates, including a Hexapro COVID-19 patch.”
The research has been published in Vaccine.
Original Article: COVID vaccine patch fights variants better than needles
More from: University of Queensland
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Needle-free vaccine patch
- Micron Biomedical Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-Free Vaccines in Children
In the same issue, the needle-free technology is recognized for its potential to be "game-changing." The landmark study demonstrated positive safety and immunogenicity of Micron's MR vaccine ...
- microneedle patch
On tests involving pig skin, the MNPs were capable of penetrating the skin and delivering the vaccine contained in the needles. Produced patches were shown to be shelf-stable for at least six ...
- Measles and rubella vaccine delivered via microarray patch shows promising results
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
- Microarray patches safe and effective for vaccinating children, trial suggests
The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from the ...
- Needle-free vaccine patches coming soon
Effective vaccines, without a needle: Since the start of the COVID-19 pandemic, researchers have doubled down on efforts to create patches that deliver life-saving drugs painlessly to the skin ...
Go deeper with Google Headlines on:
Needle-free vaccine patch
[google_news title=”” keyword=”needle-free vaccine patch” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Vaccine patch
- World News in Brief: Vaccine 'patches' trial shows promise, lowering catheter infection risk, Guantanamo detainee facing revictimisation
Few enjoy having injections and if you have children, you probably like them even less when it's time for their mandated vaccine shots.
- Vaccine ‘patches’ Trial Shows Promise, Lowering Catheter Infection Risk, Guantanamo Detainee Facing Revictimisation
Few enjoy having injections and if you have children, you probably like them even less when it’s time for their mandated vaccine shots. But now, there could be an easier alternative in the form of ...
- Microarray patches safe and effective for vaccinating children: Lancet
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic ...
- Plaster-like vaccine patches may one day replace measles and rubella jabs, research shows
A plaster-like vaccine patch could be a safe and effective alternative to injected measles and rubella immunisations, new research shows. ‘Microarray patches’ are small plaster-like devices ...
- Plaster-like vaccine patches may one day replace measles and rubella jabs, research shows
A plaster-like vaccine patch could be a safe and effective alternative to injected measles and rubella immunisations, new research shows.
Go deeper with Google Headlines on:
Vaccine patch
[google_news title=”” keyword=”vaccine patch” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]